Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer

Acta Radiologica

Volumn 50, Issue 6, 2009, Pages 638-644

  Nakagawa, M ^a   Hara, M ^a   Sakurai, K ^a   Ozawa, Y ^a   Mizuno, A ^a   Tamaki, T ^b   Nishio, M ^c   Shibamoto, Y ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

^c Nagoya PET Imaging Center   (Japan)

Author keywords

FDG PET; Lung cancer; Nodal staging; PN1

Indexed keywords

COMPUTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FDG-PET; FLUORO D GLUCOSE; LUNG CANCER; LYMPH NODE; LYMPH NODE METASTASIS; NODAL STAGING; NODAL STATUS; PN1; THERAPEUTIC STRATEGY;

BIOLOGICAL ORGANS; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; GLUCOSE; MEDICAL IMAGING; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CANCER STAGING; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOMA; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650152190     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850902971255     Document Type: Article

References (20)

1. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et al. Non-small cell lung cancer: nodalstaging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-6.
2. WahlRL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191: 371-7.
3. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 1997;52:438-41.
4. Farrell MA, McAdams HP, Herndon JE, Patz EF Jr. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000;215: 886-90.
5. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluor-odeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 2000;117:773-8.
6. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-7.
7. Eschmann SM, FriedelG, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, et al. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J NuclMed MolImaging 2002;29:804-8.
8. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-6.
9. Halter G, Buck AK, Schirrmeister H, Aksoy E, Liewald F, Glatting G, et al. Lymph node staging in lung cancer using [18F]FDG-PET. Thorac Cardiovasc Surg 2004;52: 96-101.
10. Gonzalez-Stawinski GV, Lemaire A, Merchant F, O'Halloran E, Coleman RE, Harpole DH, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 2003;126:1900-5.
11. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-13.
12. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127:1-6.
13. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survivalafter resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71: 1759-64.
14. Shiraki N, Hara M, Ogino H, Shibamoto Y, Iida A, Tamaki T, et al. False-positive and true-negative hilar and mediastinallymph nodes on FDG-PET - radiological-pathological correlation. Ann Nucl Med 2004;18: 23-8.
15. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004;45:19-27.
16. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 2005;47:235-42.
17. Inoue K, Matoba S. Counterattack of re-emerging tuberculosis after 38 years. Int J Tuberc Lung Dis 2001;5:873-5.
18. Cerfolio RJ, Ojha B, Mukherjee S, Pask AH, Bass CS, Katholi CR. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg 2003;125:938-44.
19. Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Ann Nucl Med 2008;22: 245-50.
20. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/ CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9.